Greater Glasgow and Clyde Medicines

Medicines Update -2023

GGC Medicines Update is a series of blogs with important medicines related messages relevant to all healthcare professionals across GGC.

Please note, Medicines Update blogs are correct at the time of publication.

Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact ggc.medicines.update@nhs.scot

Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC responsible for the development of Medicines Update.

If you would like to contribute to Medicines Update, click here for a guide to blog writing. When you email the committee to discuss writing a blog, you will be sent a checklist to complete prior to submitting the blog for review.

Change of Salbutamol Preferred List Choice in NHSGGC

Posted: Tuesday, December 19, 2023

Category - Medicines Update

Key messages

  • Preferred list salbutamol inhaler is now an Easyhaler® salbutamol 100 micrograms/puff dry powder inhaler
  • Reducing the number of salbutamol metered dose inhalers (MDIs) dispensed would greatly reduce the carbon impact of inhalers in NHSGGC
  • The main aims to reduce the environmental impact of inhalers are:
    • To use lower carbon footprint inhalers if appropriate for the patient
    • To improve disease control
    • To promote safe disposal of inhalers through community pharmacies
Read More...

Patient Safety: Unopposed Oestrogen Prescribing

Posted: Friday, December 8, 2023

Category - Medicines Update

Key Points:

  • Women with an intact uterus prescribed hormone replacement therapy (HRT), require both oestrogen and progestogen. The progestogen provides endometrial protection against the risk of endometrial hyperplasia and endometrial cancer.
  • It is the responsibility of the prescriber to ensure robust systems are in place to prevent women with an intact uterus receiving unopposed oestrogen.
Read More...

Transdermal opioids

Posted: Friday, December 1, 2023

Category - Medicines Update

General key messages

  • Opioid patches are only suitable for stable pain and in certain circumstances (see below)
  • Fentanyl patches are not suitable for opioid naïve patients due to their potency
  • As transdermal opioid preparations are not interchangeable, patients should remain on the same preparation, prescribed by brand name
  • Where specified brand is not available, to avoid missed doses, an alternative brand can be considered. Monitor closely for loss of pain control/opioid toxicity

 

Read More...

MyPsych has a new home!

Posted: Monday, November 27, 2023

Category - Medicines Update

Key messages:

  • MyPsych has moved to NHS Scotland Right Decisions platform
  • Effective from 1st November 2023
  • Users are required to download new app to continue to access content
Read More...

High-Cost Liquid Medicines in Adults - an update

Posted: Friday, November 17, 2023

Category - Medicines Update

Key Messages:

  • Liquid medications incur additional costs compared to other solid dosage formulations and for the majority of adult patients with swallowing difficulties, liquid formulations are not required
  • Excipients in liquid medications such as sorbitol often cause GI side-effects and the effects can be cumulative in patients prescribed multiple liquids
  • If a liquid medication is prescribed and/or supplied due to an issue sourcing solid dosage formulations, this should be reviewed as soon as the solid dosage formulation is available
Read More...

Key Medicine Shortages – November 2023

Posted: Monday, November 13, 2023

Category - Medicines Update

Key Medicine Shortages November 2023 here

Includes:

Bisacodyl (Dulcolax®) 5mg suppositories, Bumetanide 1mg and 5mg tablets, Lamotrigine 5mg dispersible tablets, Pancreatin (Pancrease® HL) gastro-resistant tablets and Testosterone enantate 250mg/ml solution for injection ampoules.

Read More...